Vaccine development

Researchers at the University of Missouri say they’ve created a new vaccine to protect cattle from bovine anaplasmosis. The disease is estimated to cost U.S. ranchers millions each year.

Scientists at SLU think they can use an existing immunization to test how well people respond to tuberculosis vaccines in development. Scientists are on the hunt for a more effective vaccine to protect people from the bacterial infection, which kills more than 1 million people a year globally.

What does your body’s reaction to the COVID-19 vaccine reveal about your immune system? And what’s with reports of a post-vaccine arm rash? In this episode, the director of St. Louis University’s Center for Vaccine Development discusses the latest vaccine news and answers listener questions.

In recent weeks, both Pfizer and Moderna announced that their COVID-19 vaccines are 95% effective. But does it mean everyone will have a vaccine by New Year’s Eve? Not quite, says Michael Kinch, associate vice chancellor at Washington University in St. Louis.

Missouri's state health director says a limited supply of vaccine could come as early as December, but supplies won't be available to the general public until spring at the earliest.

Created using a common livestock virus, the lab-engineered hybrid virus infects human cells and interacts with antibodies like the coronavirus but is safer to work with in the lab. Researchers at Washington University are now testing the new virus as a possible coronavirus vaccine candidate.

In what looks like a typical doctor’s office, Gary Newcomer, 26, waited to have his blood drawn for the last time as a participant in a trial for a Zika…

This article first appeared in the St. Louis Beacon, Nov. 23, 2011 - WASHINGTON - Citing concerns about its cost and safety, U.S. Sen. Claire McCaskill,…

This article first appeared in the St. Louis Beacon, Dec. 31, 2008 - In an old photo, members of the American Red Cross are removing two Spanish influenza…